Gursev Anmole

Gursev Anmole is a scientist specializing in multispecific antibody therapeutics at Zymeworks Inc. since May 2023, with prior experience as a Research Scientist II at Xenon Pharmaceuticals Inc. and Associate Scientist at Zymeworks Inc. focusing on antibody generation. Gursev's research background includes significant contributions at Simon Fraser University, where responsibilities ranged from leading the design of serology assays for SARS-CoV-2 detection to developing a high-throughput platform for characterizing HIV-specific T-cell receptors during a PhD in Molecular Biology and Biochemistry. In addition to technical expertise, Gursev has demonstrated leadership and mentoring skills throughout various positions, promoting a collaborative lab environment and actively participating in student organizations. Gursev holds a PhD and a Bachelor of Science in Molecular Biology and Biochemistry from Simon Fraser University.